Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders (Q40864089)

24 September 2017

1 reference

title

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders (English)

1 reference

24 September 2017

Müller N

1

1 reference

PubMed ID

9533165

24 September 2017

Ackenheil M

series ordinal

2

1 reference

24 September 2017

1 January 1998

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

24 September 2017

1 reference

24 September 2017

22

1 reference

24 September 2017

1

1 reference

24 September 2017

1-33

1 reference

Behaviorally conditioned immunosuppression

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Partial improvement in negative schizophrenic symptoms after amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 alpha in blood has direct access to cortical brain cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Depressed lymphocyte function after bereavement

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 immunoreactive innervation of the human hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Neutral Amino Acid Transport Properties of Cerebral Endothelial Cells in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Biological significance of soluble IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The role of the hypothalamo-pituitary system in the mechanism of action of reserpine and 5-hydroxytryptophan on antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The possible risk of bilirubin encephalopathy as predicted by plasma parameters in neonates with previous severe asphyxia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The "antibrain" factors in psychiatric patients' sera. I. Further studies with a hemagglutination technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Expression of T cell receptor gamma delta antigens in human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Clinical and laboratory evidence of autoimmunity in acute schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Stress, loneliness, and changes in herpesvirus latency

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Clinical-neuropathologic correlation in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Action site of circulating interleukin-1 on the rabbit brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

T-lymphocyte subpopulations in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Elevated levels of acute phase plasma proteins in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Abnormal cerebrospinal fluid protein indices in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The antiphospholipid syndrome and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

A role for interleukin-2 in the regulation of striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunoreactive interleukin-1 beta localization in the rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The monocyte-T-lymphocyte hypothesis of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunoendocrine aspects of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Reduced suppressor cell function in psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Increased soluble interleukin-2 receptor concentrations in suicide attempters.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunoregulators in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Multiple sclerosis: TNF revisited, with promise

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Haloperidol and soluble interleukin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Neuroendocrine-immune interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

PHENOTHIAZINE EFFECT ON HUMAN ANTIBODY SYNTHESIS

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

TNF alpha induces IL-6 production by astrocytes but not by microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The catecholamine hypothesis of affective disorders: a review of supporting evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Differential induction of cytokines by primary and persistent measles virus infections in human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-2 enhances the viability of primary cultured rat neocortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Tumor Necrosis Factor Modulates the Inactivation of Catecholamine Secretion in Cultured Sympathetic Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Interleukin-6 stimulates anterior pituitary hormone release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Effects of clozapine on hematopoiesis and the cytokine system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Nonsuppression of cortisol in depression and immune function.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Cytokine expression in the brain during the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: induction by cytokines and over-expression in autoimmune glands

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunopathology and viral reactivation. A general theory of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Bereavement, depression, and immune function.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Reduced Cytokine Levels and T-Cell Function in Healthy Males: Relation to Individual Differences in Subclinical Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

Vulnerability--a new view of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900179-6

7 January 2021

10.1016/S0278-5846(97)00179-6

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9533165